Standout Papers
Immediate Impact
74 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
Works of S Lutz being referenced
Update on the Systematic Review of Palliative Radiotherapy Trials for Bone Metastases
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S Lutz | 401 | 19 | 199 | 150 | 35 | 506 | |
| Alan Rodger | 220 | 23 | 270 | 128 | 21 | 510 | |
| L. Holden | 244 | 15 | 160 | 75 | 20 | 463 | |
| David Cade | 207 | 12 | 277 | 78 | 30 | 535 | |
| Megan Fiasconaro | 256 | 4 | 153 | 58 | 38 | 473 | |
| S.H. Levitt | 236 | 16 | 104 | 35 | 26 | 455 | |
| Sewit Teckie | 120 | 31 | 184 | 148 | 38 | 494 | |
| Razvan Galalae | 118 | 47 | 131 | 78 | 27 | 515 | |
| Wilhelmina H. Schreurs | 218 | 7 | 152 | 67 | 29 | 439 | |
| L Lovén | 137 | 65 | 131 | 81 | 27 | 434 | |
| Elizabeth C. Riley | 146 | 10 | 150 | 53 | 28 | 433 |
All Works
Login with ORCID to disown or claim papers
Loading papers...